{"id":"https://openalex.org/W3012710258","doi":"https://doi.org/10.1002/cncr.32804","title":"Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer","display_name":"Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer","publication_year":2020,"publication_date":"2020-03-24","ids":{"openalex":"https://openalex.org/W3012710258","doi":"https://doi.org/10.1002/cncr.32804","mag":"3012710258","pmid":"https://pubmed.ncbi.nlm.nih.gov/32208525"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.32804","doi":"https://doi.org/10.1002/cncr.32804","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.32804","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32804","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32804","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027428925","display_name":"Chelsea Kendall Osterman","orcid":"https://orcid.org/0000-0001-7101-7262","observed_orcids":["https://orcid.org/0000-0001-7101-7262"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chelsea K. Osterman","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0001-7101-7262","affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083920381","display_name":"Matthew I. Milowsky","orcid":"https://orcid.org/0000-0002-8965-8129","observed_orcids":["https://orcid.org/0000-0002-8965-8129"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew I. Milowsky","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina","Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-8965-8129","affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083920381"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"11","first_page":"2588","last_page":"2591"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.1525000035762787,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr-inhibition","display_name":"FGFR inhibition","score":0.8090000152587891},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.8730000257492065},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6859999895095825},{"id":"https://openalex.org/keywords/screening-test","display_name":"screening test","score":0.6439999938011169},{"id":"https://openalex.org/keywords/drug-selection","display_name":"drug selection","score":0.5490000247955322},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8679993152618408},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.8202794790267944},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.728920578956604},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5727244019508362},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.547762930393219},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5228621959686279},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4692886769771576},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45826369524002075},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.41814225912094116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38948577642440796},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.37276405096054077},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3112289309501648},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2799874544143677},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.18282067775726318}],"mesh":[{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017468","descriptor_name":"Receptors, Fibroblast Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051498","descriptor_name":"Receptor, Fibroblast Growth Factor, Type 3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D055088","descriptor_name":"Early Detection of Cancer","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.32804","doi":"https://doi.org/10.1002/cncr.32804","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.32804","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32804","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:32208525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32208525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1002/cncr.32804","doi":"https://doi.org/10.1002/cncr.32804","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.32804","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32804","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2696436381","display_name":"UNC-CH TRAINING PROGRAM IN HEALTH SERVICES RESEARCH","funder_award_id":"T32HS000032","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"},{"id":"https://openalex.org/G3795212036","display_name":null,"funder_award_id":"5T32-HS000032","funder_id":"https://openalex.org/F4320337444","funder_display_name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill"},{"id":"https://openalex.org/G384680359","display_name":null,"funder_award_id":"5T32 HS000032","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"},{"id":"https://openalex.org/G8605937636","display_name":null,"funder_award_id":"5T32 HS000032","funder_id":"https://openalex.org/F4320332600","funder_display_name":"University of North Carolina at Chapel Hill"}],"funders":[{"id":"https://openalex.org/F4320309342","display_name":"University of North Carolina","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337444","display_name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill","ror":"https://ror.org/0130frc33"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3012710258.pdf","grobid_xml":"https://content.openalex.org/works/W3012710258.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1563019250","https://openalex.org/W1960850967","https://openalex.org/W1982643760","https://openalex.org/W2025426616","https://openalex.org/W2031541885","https://openalex.org/W2093090488","https://openalex.org/W2128288739","https://openalex.org/W2143033064","https://openalex.org/W2193746495","https://openalex.org/W2805915033","https://openalex.org/W2886394260","https://openalex.org/W2897134528","https://openalex.org/W2921443257","https://openalex.org/W2922380387","https://openalex.org/W2954357619","https://openalex.org/W2954656275","https://openalex.org/W2964014383","https://openalex.org/W2967444750","https://openalex.org/W3012787501","https://openalex.org/W4298025629"],"related_works":["https://openalex.org/W4403590943","https://openalex.org/W4407482347","https://openalex.org/W7126042259","https://openalex.org/W4404632054","https://openalex.org/W4291202004","https://openalex.org/W4405492323","https://openalex.org/W3176330349","https://openalex.org/W2115679777","https://openalex.org/W4289334433","https://openalex.org/W4386069509"],"abstract_inverted_index":{"New":[0],"targeted":[1],"therapies":[2],"to":[3,39,50],"inhibit":[4],"fibroblast":[5],"growth":[6],"factor":[7],"receptor":[8],"(FGFR)":[9],"represent":[10],"a":[11],"promising":[12],"treatment":[13],"option":[14],"for":[15,45],"patients":[16,46],"with":[17,47],"metastatic":[18],"urothelial":[19],"carcinoma":[20],"(mUC).":[21],"Despite":[22],"significant":[23],"advances,":[24],"the":[25],"optimal":[26],"combination":[27],"of":[28,42],"drug,":[29],"disease,":[30],"genetic":[31],"alteration,":[32],"and":[33],"screening":[34],"test":[35],"that":[36],"together":[37],"lead":[38],"maximal":[40],"efficacy":[41],"FGFR":[43],"inhibition":[44],"mUC":[48],"remains":[49],"be":[51],"determined.":[52]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-03-27T00:00:00"}